INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

Infinitopes, a pioneering precision immuno-oncology company, today announced the appointments of Dan Menichella and Jo Brewer, PhD as Non-Executive Directors to its Board as the company prepares to ...

Our art critic goes room-by-room through New York’s Gilded Age house museum, reopening after nearly five years. Don’t miss the new upstairs galleries. By Holland Cotter The darkly comic ...

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

The therapy combines the immune-shielded cell-specific lentiviral vector platform, ENaBL, that reprograms immune cells inside the body with a CAR-T transgene developed by Pregene Biopharma. “By ...

Soon-to-be medical school graduates received 877 more primary care position offers in the 2025 Main Residency Match compared with the previous year, according to the National Resident Matching ...